Charles River Laboratories International is a massive, multi-billion-dollar global contract research organization and a prominent component of the S&P 500 index. The enterprise generates annual revenues exceeding four billion US dollars and commands a market capitalization of approximately 13.5 billion US dollars. Operating an extensive international network of state-of-the-art facilities, research laboratories, and manufacturing hubs across North America, Europe, and Asia, the company employs thousands of specialized scientific professionals dedicated to supporting global biopharmaceutical development.